0.6582
price down icon4.93%   -0.0333
 
loading
Schlusskurs vom Vortag:
$0.6915
Offen:
$0.6725
24-Stunden-Volumen:
832.78K
Relative Volume:
0.35
Marktkapitalisierung:
$112.32M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-111.13M
KGV:
-0.4986
EPS:
-1.32
Netto-Cashflow:
$-91.53M
1W Leistung:
+11.97%
1M Leistung:
+44.87%
6M Leistung:
-56.17%
1J Leistung:
-77.64%
1-Tages-Spanne:
Value
$0.65
$0.68
1-Wochen-Bereich:
Value
$0.5372
$0.698
52-Wochen-Spanne:
Value
$0.36
$4.06

Tenaya Therapeutics Inc Stock (TNYA) Company Profile

Name
Firmenname
Tenaya Therapeutics Inc
Name
Telefon
415-865-2066
Name
Adresse
171 OYSTER POINT BLVD., SUITE 500, SOUTH SAN FRANCISCO
Name
Mitarbeiter
97
Name
Twitter
Name
Nächster Verdiensttermin
Name
Neueste SEC-Einreichungen
Name
TNYA's Discussions on Twitter

Vergleichen Sie TNYA mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
TNYA
Tenaya Therapeutics Inc
0.6582 112.32M 0 -111.13M -91.53M -1.32
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
444.13 115.95B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
527.72 56.52B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
319.13 39.44B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
560.82 35.14B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
241.25 28.51B 3.81B -644.79M -669.77M -6.24

Tenaya Therapeutics Inc Stock (TNYA) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2024-06-10 Eingeleitet William Blair Outperform
2023-11-30 Eingeleitet Leerink Partners Outperform
2022-06-15 Eingeleitet H.C. Wainwright Buy

Tenaya Therapeutics Inc Aktie (TNYA) Neueste Nachrichten

pulisher
Jun 15, 2025

Brokerages Set Tenaya Therapeutics, Inc. (NASDAQ:TNYA) Price Target at $6.25 - Defense World

Jun 15, 2025
pulisher
Jun 12, 2025

Millennium Management LLC Sells 174,447 Shares of Tenaya Therapeutics, Inc. (NASDAQ:TNYA) - Defense World

Jun 12, 2025
pulisher
Jun 12, 2025

Tenaya Therapeutics (NASDAQ:TNYA) and Alpha Cognition (NASDAQ:ACOG) Critical Survey - Defense World

Jun 12, 2025
pulisher
Jun 11, 2025

Squarepoint Ops LLC Decreases Stock Position in Tenaya Therapeutics, Inc. (NASDAQ:TNYA) - Defense World

Jun 11, 2025
pulisher
Jun 06, 2025

Nuveen Asset Management LLC Buys 69,377 Shares of Tenaya Therapeutics, Inc. (NASDAQ:TNYA) - Defense World

Jun 06, 2025
pulisher
Jun 03, 2025

Deutsche Bank AG Acquires 97,318 Shares of Tenaya Therapeutics, Inc. (NASDAQ:TNYA) - Defense World

Jun 03, 2025
pulisher
May 31, 2025

Northern Trust Corp Grows Stock Holdings in Tenaya Therapeutics, Inc. (NASDAQ:TNYA) - Defense World

May 31, 2025
pulisher
May 30, 2025

Tenaya Therapeutics Appoints New Directors at Annual Meeting - TipRanks

May 30, 2025
pulisher
May 21, 2025

Tenaya Therapeutics, Inc. (NASDAQ:TNYA) Receives $6.25 Average Target Price from Brokerages - Defense World

May 21, 2025
pulisher
May 18, 2025

Price T Rowe Associates Inc. MD Sells 2,892,201 Shares of Tenaya Therapeutics, Inc. (NASDAQ:TNYA) - Defense World

May 18, 2025
pulisher
May 17, 2025

Tenaya therapeutics SVP Higa Tomohiro sells $615 in stock By Investing.com - Investing.com Nigeria

May 17, 2025
pulisher
May 16, 2025

Tenaya Therapeutics chief medical officer sells $1,300 in stock By Investing.com - Investing.com Nigeria

May 16, 2025
pulisher
May 16, 2025

Tenaya Therapeutics chief medical officer sells $1,300 in stock - Investing.com Australia

May 16, 2025
pulisher
May 16, 2025

Tenaya therapeutics SVP Higa Tomohiro sells $615 in stock - Investing.com

May 16, 2025
pulisher
May 16, 2025

Tenaya Therapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4) - The Manila Times

May 16, 2025
pulisher
May 15, 2025

Tenaya Therapeutics Awards Major Stock Options Package: 461K Shares for Strategic New Hires - Stock Titan

May 15, 2025
pulisher
May 15, 2025

Greenlane Renewables Announces First Quarter 2025 Financial Results - The Globe and Mail

May 15, 2025
pulisher
May 15, 2025

Barclays PLC Sells 184,837 Shares of Tenaya Therapeutics, Inc. (NASDAQ:TNYA) - Defense World

May 15, 2025
pulisher
May 13, 2025

Tenaya Therapeutics (TNYA) to Showcase Key Research at ASGCT 2025 | TNYA Stock News - GuruFocus

May 13, 2025
pulisher
May 13, 2025

Tenaya Therapeutics to Highlight Capsid Engineering, Gene Editing and Manufacturing Research at the ASGCT 28th Annual Meeting - The Manila Times

May 13, 2025
pulisher
May 13, 2025

Tenaya Therapeutics to Present Five Abstracts on Innovative Heart Disease Gene Therapies at ASGCT 2025 Annual Meeting - Nasdaq

May 13, 2025
pulisher
May 13, 2025

Tenaya Therapeutics to Highlight Capsid Engineering, Gene - GlobeNewswire

May 13, 2025
pulisher
May 13, 2025

Hsbc Holdings PLC Purchases New Position in Tenaya Therapeutics, Inc. (NASDAQ:TNYA) - Defense World

May 13, 2025
pulisher
May 12, 2025

Equities Analysts Issue Forecasts for TNYA Q2 Earnings - Defense World

May 12, 2025
pulisher
May 12, 2025

Tenaya Therapeutics’ (TNYA) Buy Rating Reiterated at Chardan Capital - Defense World

May 12, 2025
pulisher
May 10, 2025

We're A Little Worried About Tenaya Therapeutics' (NASDAQ:TNYA) Cash Burn Rate - Yahoo Finance

May 10, 2025
pulisher
May 09, 2025

Chardan Capital Maintains Buy Rating for Tenaya Therapeutics (TNYA) | TNYA Stock News - GuruFocus

May 09, 2025
pulisher
May 08, 2025

Tenaya Therapeutics Reports Q1 2025 Financial Results - TipRanks

May 08, 2025
pulisher
May 07, 2025

Tenaya (TNYA) Reports Promising Clinical Trial Developments and Financial Outlook | TNYA Stock News - GuruFocus

May 07, 2025
pulisher
May 07, 2025

Tenaya Therapeutics Reports First Quarter 2025 Financial Results and Provides Business Update - GlobeNewswire

May 07, 2025
pulisher
May 02, 2025

A Cautious Investment in the Drone Sector - The Globe and Mail

May 02, 2025
pulisher
Apr 30, 2025

Geode Capital Management LLC Sells 27,419 Shares of Tenaya Therapeutics, Inc. (NASDAQ:TNYA) - Defense World

Apr 30, 2025
pulisher
Apr 28, 2025

Layoff Tracker: Ono Cuts 83 Employees in Massachusetts - BioSpace

Apr 28, 2025
pulisher
Apr 28, 2025

Why To Invest In Tenaya Therapeutics Inc (NASDAQ: TNYA) Stock? - Marketing Sentinel

Apr 28, 2025
pulisher
Apr 25, 2025

H.C. Wainwright maintains Buy on Tenaya Therapeutics stock By Investing.com - Investing.com South Africa

Apr 25, 2025
pulisher
Apr 25, 2025

H.C. Wainwright maintains Buy on Tenaya Therapeutics stock - Investing.com Australia

Apr 25, 2025
pulisher
Apr 24, 2025

TNYATenaya Therapeutics, Inc. Latest Stock News & Market Updates - Stock Titan

Apr 24, 2025
pulisher
Apr 24, 2025

Tenaya reports progress in ARVC gene therapy study - Investing.com

Apr 24, 2025
pulisher
Apr 24, 2025

Tenaya Therapeutics Presents Interim Data from RIDGE™ Natural History and Seroprevalence Study of Adults with PKP2-associated ARVC at Heart Rhythm 2025 - The Manila Times

Apr 24, 2025
pulisher
Apr 24, 2025

Tenaya Therapeutics Presents Interim Data from RIDGE™ - GlobeNewswire

Apr 24, 2025
pulisher
Apr 24, 2025

Major Breakthrough: 175-Patient ARVC Study Shows 93% Could Benefit from New Gene Therapy Treatment - Stock Titan

Apr 24, 2025
pulisher
Apr 21, 2025

Strategy (MSTR) Buys Another $556 Million Worth of Bitcoin - The Globe and Mail

Apr 21, 2025
pulisher
Apr 19, 2025

Tenaya Therapeutics faces Nasdaq delisting over share price By Investing.com - Investing.com India

Apr 19, 2025
pulisher
Apr 18, 2025

Tenaya Therapeutics faces Nasdaq delisting over share price - Investing.com Australia

Apr 18, 2025

Finanzdaten der Tenaya Therapeutics Inc-Aktie (TNYA)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading

Tenaya Therapeutics Inc-Aktie (TNYA) Insiderhandel

Insiderhandel Beziehung Datum Transaktion Kosten #Aktien Wert ($) #Aktien Gesamt
Tingley Whittemore
Chief Medical Officer
May 16 '25
Sale
0.44
2,937
1,300
171,856
Ali Faraz
Chief Executive Officer
May 16 '25
Sale
0.44
3,189
1,412
317,325
Higa Tomohiro
SVP, Finance
Mar 10 '25
Sale
0.54
2,482
1,336
99,690
Tingley Whittemore
Chief Medical Officer
Mar 10 '25
Sale
0.54
7,398
3,983
174,793
Ali Faraz
Chief Executive Officer
Mar 10 '25
Sale
0.54
9,741
5,245
320,514
$20.42
price down icon 1.37%
$35.45
price up icon 0.65%
$21.06
price down icon 1.92%
$101.83
price down icon 0.41%
$105.86
price down icon 0.39%
biotechnology ONC
$244.00
price down icon 3.69%
Kapitalisierung:     |  Volumen (24h):